Private Equity
NMS Capital-backed Anne Arundel Dermatology Management partnered with four groups in North Carolina: Southern Dermatology; Azalea Skin Treatment Center; Raleigh Dermatology Associates, and Skin Solutions; and Audrey F. Echt. The four practices have four locations and about 20 provides serving the Raleigh, North Carolina market. With the addition of the four practices, Anne Arundel Dermatology supports 55 clinic locations across four states and more than 150 providers.
3 min read · 30 September 2019
The agreement values the Bay City, Michigan, hospice-care provider north of $1 billion, the people said, equating to a low-teens multiple of Ebitda.
2 min read · 30 September 2019
LLR Partners has invested in Corestream. Financial terms weren’t announced. Corestream provides a platform that connects employees with voluntary benefits.
3 min read · 30 September 2019
BayMark Health Services, a PE-backed network of clinics looking to combat the nation’s opioid epidemic, has kicked off a sales process, according to people familiar with the matter.
2 min read · 27 September 2019
How 'balance billing' wrangling could impact healthcare M&A
2 min read · 26 September 2019
Council Capital and Baird Capital said Sept. 26 that they sold their stakes in emids to New Mountain Capital. Financial terms weren’t announced. Emids, of Nashville, provides technology services and solutions for healthcare payers and providers.
3 min read · 26 September 2019
American Physician Partners, a private equity-backed provider of outsourced emergency department services to hospitals, is evaluating a sale, according to several people familiar with the matter.
3 min read · 25 September 2019
BioNTech SE, a German biotech company focused on treating cancer and other serious diseases, is planning on raising about $250 million for its IPO after pricing its 13.2 million shares at a price between $18 and $20 per share. The company plans on trading the stock on the NASDAQ under the ticker symbol "BNTX." J.P. Morgan, BofA Merrill Lynch, UBS Investment Bank and SVB Leerink are the lead underwriters. BioNTech's investors include Fidelity Management & Research Company.
3 min read · 25 September 2019
CVC Strategic Opportunities has agreed to acquire a 50 percent stake in DFE Pharma, a German excipients manufacturer for the pharmaceutical industry. The seller is Fonterra. No financial terms were disclosed.
3 min read · 25 September 2019
EyeSouth Partners, a portfolio company of Shore Capital Partners, has invested in Eye Center of North Florida. No financial terms were disclosed. ECNF was formed in 1999 following the merger of the Newberry Eye Clinic and Gulf Coast Eye Clinic.
3 min read · 25 September 2019
